
PacificHealth Laboratories Inc. Stock Analysis PHLI
PacificHealth Laboratories, founded in 1996 by two prominent scientists, started with a singular purpose – to help athletes achieve their personal goals. The company is headquartered in Parsippany, New Jersey and currently employs 8 full-time employees. The firm collaborates with various nutritionists, biochemists and sports scientists. Its product categories include endurance, recovery, thrive and wellness. Its product collections include Accelerade 4:1, Endurox R4 4:1, Endurox Excel, Gummies, Nutragize, Accel Gel's 4:1, and 2nd Surge. Accelerade is a sports drink that contains protein in a patented 4:1 carbohydrate-protein ratio. Endurox R4, with its patented 4:1 carb-protein ratio is focused on muscle recovery. The firm's products include Endurox Excel, Healthy Joints, Daily Wellness, Anti-inflammatory, Ashwagandha, Immuno ARMOR, TurboTest, Adreno+, Mushroom X, P2Biotics, EstroCell, Accel Gel, 2nd Surge, water bottle and Nutrient Timing.
Read More PacificHealth Laboratories Inc (PHLI) Chart
Key Statistics of PacificHealth Laboratories Inc (PHLI)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
-P/E Ratio (TTM)
-52 Week Range
Market Cap
-Avg. Volume
-Dividend Yield
-Financial Metrics & Statements of PacificHealth Laboratories Inc (PHLI)
FAQ's for PacificHealth Laboratories Inc (PHLI)
- According to Musaffa’s Shariah screening methodology, PacificHealth Laboratories Inc (PHLI) is currently classified as NOT COVERED as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
Alternate Halal Stocks for PacificHealth Laboratories Inc (PHLI)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.